A recent review of treatments for RLS and PLMD by the American Academy of Sleep Medicine has recommended that dopamine agonists should not be used as initial therapy for RLS due to the adverse effects of augmentation. This strengthens and supports the existing advice against the use of dopamine
This year we were delighted to present the Andrew Wilson Award to Dr Mark Buchfuhrer who has helped so many UK RLS sufferers. And we were even more delighted when he recorded this video response which we showed at the AGM.
A BIG THANK YOU to all 3722 of you who responded to our survey in August. We intend to use the data to galvanise press and parliamentary attention on RLS issues. However initial analysis has highlighted important areas to feed back on – click the download for more information
Released for Restless Legs Awareness Day, RLS sufferers share their experience of living with RLS, as well as the serious side effects of what is often the first line treatment from the UK medical establishment. With a perspective from Dr Julian Spinks of RLS-UK
A MailOnline article reports on the side effects of one of the most commonly prescribed drugs for RLS
Below is the link to a short clip about RLS featured on BBC Morning Live on 8th April 2024. https://www.facebook.com/share/v/GmdDew7LTuqnzeb4/
A sponsorship of €10,000 will be awarded to be freely used to achieve the goals presented in the application. This scholarship aims to honour new initiatives and make it possible to initiate or continue projects that may need additional funding. The winning researcher will be invited to present her/his/their
We are pleased to announce that we have added Instagram to our social media suite of communications. To see our posts on Instagram search RestlessLegsUk and click follow.
